Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingEculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
The global aHUS registry: methodology and initial patient characteristics. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingThe global aHUS registry: methodology and initial patient characteristics.
Pregnancy-related thrombotic microangiopathies: Clues from complement biology. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingPregnancy-related thrombotic microangiopathies: Clues from complement biology.
How we manage thrombotic microangiopathies in pregnancy. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingHow we manage thrombotic microangiopathies in pregnancy.
Pulling the Trigger in Atypical Hemolytic Uremic Syndrome: The Role of Pregnancy Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingPulling the Trigger in Atypical Hemolytic Uremic Syndrome: The Role of Pregnancy
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingPregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingGenetic studies into inherited and sporadic hemolytic uremic syndrome.
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingCritical appraisal of eculizumab for atypical hemolytic uremic syndrome
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Post author:ahusalliance Post published:December 19, 2016 Post category: Post comments:0 Comments Continue ReadingEculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
